Archexin (RX 0201) - Rexahn, Zhejiang Haichang Bio-Tech
Rexahn: Annual Report 2015 (Rexahn Pharmaceuticals, Inc) - Mar 19, 2016 - Anticipated expiry of patents in US and ex-US between 2020-2030 
Anticipated patent expiry • Oncology
http://investors.rexahn.com/secfiling.cfm?filingID=1140361-16-57543
 
Mar 19, 2016
 
.